RT @MRCRWG: Pioneering methodological work enabled successful recruitment to the ProtecT trial https://t.co/QKtsPDzIHP
Pioneering methodological work enabled successful recruitment to the ProtecT trial https://t.co/QKtsPDzIHP
RT @iurojc: This paper being discussed on #urojc now. https://t.co/JjBVlQil2T https://t.co/ZkfGK9VRSC
This paper being discussed on #urojc now. https://t.co/JjBVlQil2T https://t.co/ZkfGK9VRSC
RT @jimgthornton: No surpise from ProtecT. Surg v radio v watch wait 4 local prostate Ca. No mort diff. WW wins on sex & continence. https…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @prokarurol: As I read the notification from the @nytimes I wondered about "mixed messages" - a negative, positive trial? https://t.co/B…
RT @drjonrees: Been waiting for this for some time - PROTECT study #prostatecancer https://t.co/NNVMdKTEkc #activesurveillance looking good…
RT @iurojc: How do you think ProtecT results will steer the early prostate cancer detection & treatment debate? #urojc https://t.co/JjBVlQi…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @cancer_K2A: No diff in mortality 10yr after monitoring, #surgery or radio for localized #prostatecancer https://t.co/GGiWsr0VZK https:/…
RT @sandraturner49: New prostate c study out. Better urinary/sexual fn radiation vs surgery https://t.co/6kZUzUZhNl @seanparnell @Targeting…
No surpise from ProtecT. Surg v radio v watch wait 4 local prostate Ca. No mort diff. WW wins on sex & continence. https://t.co/7nemKlq6Tu
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
ProtecT results published: same mortality, but different tox profiles for observation, RT or surgery https://t.co/7tRBCpuyNZ #radonc
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer _ https://t.co/kLeMKzvYpY
RT @sandraturner49: New prostate c study out. Better urinary/sexual fn radiation vs surgery https://t.co/6kZUzUZhNl @seanparnell @Targeting…
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
RT @sandraturner49: New prostate c study out. Better urinary/sexual fn radiation vs surgery https://t.co/6kZUzUZhNl @seanparnell @Targeting…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
New prostate c study out. Better urinary/sexual fn radiation vs surgery https://t.co/6kZUzUZhNl @seanparnell @TargetingCancer @sophiescott2
#overtreatment Amazing! There is no difference in mortality whether if we treat or not prostate cancer https://t.co/tGqLTWwHx0
RT @sandraturner49: Great news for men w prostate ca. Effective choices- talk to a radiation oncologist @TargetingCancer @JulieMcCrossin ht…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
ProtecT data out but 77% patients in study were Gleason 6, 76% T1c... no surprise no difference in overall survival: https://t.co/5qgrCr34Xn
RT @petergorayski: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/8OBb4nMPhX
RT @CoyneoftheRealm: 10-Year Outcomes for Surgery, Radiotherapy for Localized Prostate Cancer no Better than Watchful Waiting @NEJM https:…
RT @sandraturner49: Great news for men w prostate ca. Effective choices- talk to a radiation oncologist @TargetingCancer @JulieMcCrossin ht…
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/II4vvZ10Yv
Great news for men w prostate ca. Effective choices- talk to a radiation oncologist @TargetingCancer @JulieMcCrossin https://t.co/6kZUzUZhNl
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare https://t.co/6kZUzUZhNl
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
Un article qui permettra aux patients ayant eu un diagnostic de cancer localisé de la prostate de choisir le trt https://t.co/HDREo8ttYp
RT @jmmrad: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/cBXYv9EYH4
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @zakkohane: ‘Watchful waiting’ looks like a #precisionmedicine therapeutic in #prostate #cancer https://t.co/pqOkn7vF1Z https://t.co/WI…
10 yr comparison of active monitoring, radiotherapy vs surgery 4 clinically localized #prostatecancer @eugeneahn https://t.co/DIDRhKfxO3
‘Watchful waiting’ looks like a #precisionmedicine therapeutic in #prostate #cancer https://t.co/pqOkn7vF1Z https://t.co/WIQSmmy3Zl
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @AtulGupta_MD: And from @NEJM today, 99% 10yr #prostatecancer survival whether surgery, rad, or monitoring. https://t.co/cdd3iFA5CH http…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/09Ic61ftCi
And from @NEJM today, 99% 10yr #prostatecancer survival whether surgery, rad, or monitoring. https://t.co/cdd3iFA5CH https://t.co/kDVD8V8a4b
RT @sabinbmotwanimd: Long awaited results of the ProtecT study in @NEJM published today https://t.co/2rstXGHllD. #radonc #pcsm
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @iurojc: How do you think ProtecT results will steer the early prostate cancer detection & treatment debate? #urojc https://t.co/JjBVlQi…
How do you think ProtecT results will steer the early prostate cancer detection & treatment debate? #urojc https://t.co/JjBVlQil2T
NEJM/Cohort(ProtecT).1999~2009年にPSA検査で限局性前立腺癌と診断され,経過観察,拡大前立腺切除術,放射線外照射を行った患者の10年後前立腺癌死亡は1000人年中1.5,0.9,0.7で違いなし.総死亡もhttps://t.co/1FbF2NJNTV
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/VrkVq995kr
RT @petergorayski: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/8OBb4nMPhX
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/jnysjBXVT4
RT @iurojc: ProtecT is finally out. Let's discuss. Don't forget to include #urojc in your tweets. https://t.co/JjBVlQil2T
ProtecT is finally out. Let's discuss. Don't forget to include #urojc in your tweets. https://t.co/JjBVlQil2T
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
Also no diff in mets or disease progression. How 'bout them apples @DrRKSingal @WallisCJD? Here's link to article https://t.co/eyKVhnEPqd
RT @petergorayski: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/8OBb4nMPhX
RT @CoyneoftheRealm: 10-Year Outcomes for Surgery, Radiotherapy for Localized Prostate Cancer no Better than Watchful Waiting @NEJM https:…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/8OBb4nMPhX
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
Landmark study of #prostatecancer for surgery vs radiation vs active surveillance https://t.co/yUJZB11WBl
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/k2KPJljU8Q
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
No diff in mortality 10yr after monitoring, #surgery or radio for localized #prostatecancer https://t.co/GGiWsr0VZK https://t.co/9L1MSkcCyk
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized #ProstateCancer via @NEJM. https://t.co/25sPNj9y6D
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @drjonrees: Been waiting for this for some time - PROTECT study #prostatecancer https://t.co/NNVMdKTEkc #activesurveillance looking good…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
As I read the notification from the @nytimes I wondered about "mixed messages" - a negative, positive trial? https://t.co/B2C0Xecs84
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
Been waiting for this for some time - PROTECT study #prostatecancer https://t.co/NNVMdKTEkc #activesurveillance looking good #mustread
RT @CoyneoftheRealm: 10-Year Outcomes for Surgery, Radiotherapy for Localized Prostate Cancer no Better than Watchful Waiting @NEJM https:…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
Long awaited results of the ProtecT study in @NEJM published today https://t.co/2rstXGHllD. #radonc #pcsm
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/zDyEXme72G
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
.@sethmnookin _localized_ prostate cancer, also reduction in disease progression and metastasis. https://t.co/1M3T649Ikd
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/vK6BxhLfhH